Chemotherapy, adjuvant
Showing 1 - 25 of >10,000
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- mFOLFIRINOX adjuvant chemotherapy
- mFOLFOX6/XELOX adjuvant chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 12, 2023
Therapeutic Mammoplasty on the Start of Adjuvant Chemotherapy
Completed
- Effect of Therapeutic Mammoplasty on Adjuvant Chemotherapy
- therapeutic mammoplasty
- (no location specified)
Jun 16, 2023
Uterine Cervical Tumors, Chemoradiotherapy, Adjuvant Chemo Trial in Liuzhou (paclitaxel combined with platinum)
Recruiting
- Uterine Cervical Neoplasms
- +2 more
- paclitaxel combined with platinum
-
Liuzhou, Guangxi, Chinathe Fourth Affiliated Hospital of Guangxi Medical University
Feb 16, 2023
Gastrointestinal Tumors, Immunonutrition, Postoperative Adjuvant Chemo Trial in Shenyang (Immunonutrition (Su yusu),
Recruiting
- Gastrointestinal Tumors
- +2 more
- Immunonutrition （Su yusu)
- fluorouracil based chemotherapy regimens
-
Shenyang, Liaoning, ChinaThe First Hospital of China Medical University
Oct 13, 2023
Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as
Completed
- Colorectal Cancer Metastatic
- Targeted agent
- (no location specified)
Aug 31, 2023
Colorectal Cancer, Chemo Effect Trial in GuangZhou (FOLFOX chemo regimens, Bevacizumab)
Not yet recruiting
- Colorectal Cancer
- Chemotherapy Effect
- FOLFOX chemotherapy regimens
- Bevacizumab
-
GuangZhou, Guangdong, ChinaThe Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023
Relative Dose Intensity of Adjuvant Chemotherapy in Older ER+
Not yet recruiting
- Breast Cancer
- (no location specified)
Aug 21, 2023
Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Antivascular therapy
- Chemotherapy
- (no location specified)
Jun 11, 2023
Endometrial Carcinoma Trial in Sohag (Paclitaxel/epirubcin/carboplatin, Paclitaxel/carboplatin)
Not yet recruiting
- Endometrial Carcinoma
-
Sohag, EgyptSohag university Hospital
Oct 25, 2023
Gastric Cancer Trial in Shanghai (Serplulimab, Trastuzuma, Chemotherapy)
Recruiting
- Gastric Cancer
- Serplulimab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 27, 2023
Colon Cancer Trial in Daegu (timing to initiate the adjuvant chemo)
Active, not recruiting
- Colon Cancer
- timing to initiate the adjuvant chemotherapy
-
Daegu, Korea, Republic of
- +1 more
Dec 21, 2022
Peritoneal Metastases From Colorectal Cancer Trial in Milano (Pressurized intraperitoneal aerosol chemo (PIPAC))
Recruiting
- Peritoneal Metastases From Colorectal Cancer
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC)
-
Milano, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Oct 16, 2023
Esophageal Cancer Trial (Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B), Adjuvant chemoradiotherapy)
Not yet recruiting
- Esophageal Cancer
- Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B)
- Adjuvant chemoradiotherapy
- (no location specified)
Dec 19, 2022
Gastric Cancer Trial in Taoyuan (Frailty intervention measures)
Recruiting
- Gastric Cancer
- Frailty intervention measures
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Sep 20, 2023
Immunotherapy, Chemo Trial in Guandong (Camrelizumab)
Recruiting
- Immunotherapy
- Chemotherapy
-
Guandong, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 22, 2023
TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- (no location specified)
May 8, 2023
Colorectal Cancer, Liver Metastases, Circulating Tumor Cell Trial in GuangZhou (Colorectal cancer resection combined with liver
Recruiting
- Colorectal Cancer
- +3 more
- Colorectal cancer resection combined with liver metastasis resection.
- FOLFOX chemotherapy regimen
-
GuangZhou, Guangdong, ChinaThe Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 14, 2023
Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)
Not yet recruiting
- Breast Cancer
- Ovarian Function Suppression + Aromatase Inhibitor
- Adjuvant Chemotherapy + Ovarian Function Suppression
- (no location specified)
May 19, 2023
Pancreatic Carcinoma, Adjuvant Chemo, Cancer-related Fatigue Trial in Hangzhou (Codonopsis, Placebo)
Recruiting
- Pancreatic Carcinoma
- +2 more
- Codonopsis
- Placebo
-
Hangzhou, Other (Non U.s.), ChinaZhejiang Provincial People'S Hospital
Nov 10, 2022
Colon Cancer Trial (mFOLFIRINOX-FOLFIRI intensified chemo, FOLFOX or CAPOX adjuvant chemo)
Not yet recruiting
- Colon Cancer
- mFOLFIRINOX-FOLFIRI intensified chemotherapy
- FOLFOX or CAPOX adjuvant chemotherapy
- (no location specified)
Sep 6, 2022
Esophageal Cancer, Surgery, Neoadjuvant Treatment Trial in Zhengzhou (Neoadjuvant immunochemo)
Recruiting
- Esophageal Cancer
- +3 more
- Neoadjuvant immunochemotherapy
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
Oct 2, 2022
Pancreatic Cancer Trial in United States (Gemcitabine and Capecitabine)
Recruiting
- Pancreatic Cancer
- Gemcitabine and Capecitabine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Dec 31, 2022
Esophageal Squamous Cell Carcinoma Trial in Shantou (Tislelizumab)
Recruiting
- Esophageal Squamous Cell Carcinoma
-
Shantou, Guangdong, ChinaCancer Hospital of Shantou University Medical College
Aug 2, 2023
Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy
Recruiting
- Urothelial Carcinoma
- Radiotherapy
- +2 more
-
Beijing, China
- +2 more
Nov 2, 2023